C-BE5ESana Biotechnology
engineered cells, gene repair, cell replacement
replacementreplacingcell therapy
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
All companiesC-BE5E
C-BE5EC-BE5Eengineered cells, gene repair, cell replacement
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Sana Biotechnology engineered cells, gene repair, cell replacement
Sana Biotechnology is focused on creating and delivering engineered cells as medicines for patients. Its work centers on repairing and controlling genes, replacing missing or damaged cells, and making therapies broadly available. The company is advancing programs for type 1 diabetes, B-cell cancers, and B-cell related autoimmune disorders using hypoimmune and fusogen technologies.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Sana Biotechnology — Translational · Bottom quartile. Derived deterministically from 9 extracted project(s). Most-advanced status: phase 1. Band: translational. Modifiers: +5 depth (3 programs at…
Source: Deterministic